Global Dry Eye Disease Market to Reach $8.21 Billion by 2028 at a CAGR of 4.71% – ResearchAndMarkets.com

Global Dry Eye Disease Market to Reach $8.21 Billion by 2028 at a CAGR of 4.71% – ResearchAndMarkets.com




Global Dry Eye Disease Market to Reach $8.21 Billion by 2028 at a CAGR of 4.71% – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Dry Eye Disease Market By product, By distribution channel & By region-Forecast Analysis 2022-2028” report has been added to ResearchAndMarkets.com’s offering.

Global Dry Eye Disease Market size was valued at USD 5.95 billion in 2021, and it is expected to reach a value of USD 8.21 billion by 2028, at a CAGR of 4.71% during the forecast period (2022- 2028).

According to several research carried out all over the world, the prevalence of dry eye illness is thought to be between 8% and 34%. Ageing, diabetes, LASIK surgery, the use of specific drugs, and environmental factors like pollution are only a few of the related risk factors for dry eye disease. The demand for treatments and medications is influenced by these elements. Global geriatric population growth is predicted to result in an increase in the number of patients with dry eye disease.

Segments covered in this report

The global dry eye disease market is segmented based on the product, distribution channel and region.

  • Based on the product, it is segmented into artificial tears, anti-inflammatory drugs, punctal plugs, secretagogues, and others.
  • Based on distribution channel, it is segmented into hospital pharmacies, independent pharmacies & drug stores, and online pharmacies.
  • Based on region it is categorized into North America, Europe, Asia-Pacific, Latin America, and MEA.

Driver

The market for dry eye disease is predicted to have strong growth during the assessment period of 2022-2028 due to the rise in the geriatric population and the rising number of eye-related ailments among them. The rising incidence of these disorders has compelled numerous researchers and developers to find effective treatment choices, which has ultimately enhanced the dry eye disease market’s growth prospects.

Restraint

For the earliest stages of treating dry eye illness, many patients and doctors turn to over-the-counter artificial tears. A few somewhat pricey prescription drugs are recommended for the treatment of dry eye conditions. Additionally, these drugs only address the outward manifestations of dry eye illness; they do not address its underlying causes. These factors are likely to hinder market growth during the forecast period.

Market Trends

The market for dry eye illness may have great growth prospects due to the increasing emergence of novel treatments as a result of intense research and development efforts. A significant growth driver for the dry eye disease market will be the rising public awareness of dry eye disease brought on by numerous government and non-government efforts. Furthermore, the market for dry eye disease will have strong development potential because of the speedy regulatory authority approval of novel treatment methods.

Key Topics Covered:

Executive Summary

Market overview

Parent Market Analysis

Market overview

Market size

KEY MARKET INSIGHTS

COVID IMPACT

MARKET DYNAMICS & OUTLOOK

Global Dry Eye Disease Market by Product

Global Dry Eye Disease Market by Distribution Channel

Market Size by Region

Companies Mentioned

  • Allergan (Ireland)
  • Alcon (Switzerland)
  • Novartis AG (Switzerland)
  • Santen Pharmaceutical Co., Ltd. (Japan)
  • OASIS Medical (US)
  • Sun Pharmaceutical Industries Ltd (India)
  • Otsuka Pharmaceutical Co., Ltd. (Japan)
  • Sentiss Pharma Pvt. Ltd. (India)
  • Johnson & Johnson Vision Care, Inc. (US)
  • VISUfarma (Netherlands)

For more information about this report visit https://www.researchandmarkets.com/r/egewyu

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900